Insights & Resources

The instances of urgent care clinic visits have returned to pre-pandemic levels, but COVID-related services still make up a large percentage of the total volume.

The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.

High-growth specialties are influencing the fair market value of ambulatory surgery centers and setting new standards for premium valuations.

Discovery target lists can enhance asset recovery efforts in litigation and judgment enforcement by providing a strategic roadmap for enforcement and collections.

Explore Weaver's insights on the current health care deal volume decline and valuation.

By adopting best practices for fraud prevention and fostering a culture of transparency, NFPs can safeguard their resources and continue to make a positive impact.

Discover how AI and machine learning are revolutionizing forensic accounting by enhancing transaction reviews, anomaly detection and risk assessments.

Recent trends in financial performance & provider productivity show challenges facing medical groups related to practice margins. What does it mean for valuations?

Whether preceding an M&A transaction or another executive hire, due diligence identifies any red flags before inking a high-stakes deal.

In any health care segment, buyer concentration can have an effect on valuation pricing and is one of the key macro-dynamics that should be considered in a health care valuation analysis.

Discover the pivotal role of data analytics in FCPA compliance to ensure integrity and ethical business conduct around the globe.

If FinCEN’s proposed rule is adopted, SEC Registered Investment Advisers and Exempt Reporting Advisers would be subject to FinCEN’s AML and CFT requirements.